Whether youre looking to boost immunity, support metabolism, recover after illness or travel, or enhance skin and hair health, our customized treatments help you feel better from the inside out
Add-on to 1-3 oral anti-hyperglycemic agents (metformin, sulfonylurea, or SGLT-2 inhibitor) SURPASS-4 (NCT03730662) was a 104-week open-label trial (52-week primary endpoint) that randomized 2002 adult patients with type 2 diabetes mellitus with increased cardiovascular risk to subcutaneous MOUNJARO 5 mg, MOUNJARO 10 mg, MOUNJARO 15 mg once weekly, or insulin glargine 100 units/mL once daily (1:1:1:3 ratio) on a background of metformin (95%) and/or sulfonylureas (54%) and/or SGLT2 inhibitors (25%)
Take them with you wherever you gowhether at the gym, work, or travelingso you never miss out on your daily dose of B12
Potential benefits of Dihexa what research suggests Important: The following reflects findings from preclinical (animal) research and early research reports